← Back to Search

Behavioural Intervention

Effects of Tobacco Flavoring and Liquid Composition on Vaping Topography for Tobacco-Related Cancer

N/A
Recruiting
Led By Richard O'Connor
Research Sponsored by Roswell Park Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 months
Awards & highlights

Study Summary

This trial tests how tobacco flavor and nicotine composition affect how people vape. Understanding this could help assess health risks from vaping.

Who is the study for?
This trial is for daily vapers of nicotine products who don't use other tobacco items and consider themselves in good health. Women able to have children must test negative for pregnancy. Participants need to understand the study's experimental aspect and sign a consent form.Check my eligibility
What is being tested?
The study examines how tobacco flavoring and liquid composition, including lab-made or natural nicotine, affect vaping habits (topography). It aims to understand the impact on appeal, risk perception, and usage patterns which are crucial for assessing health risks.See study design
What are the potential side effects?
While specific side effects aren't listed for this observational trial, general risks may include irritation from flavors or synthetic nicotine used during vaping sessions as part of the study.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Puff Topography
Secondary outcome measures
Subjective questionnaires of product evaluation

Trial Design

1Treatment groups
Experimental Treatment
Group I: Vaping -Experimental Treatment3 Interventions
Description The order of directed and ad libitum bouts are randomized within participants at each session. SESSION 1: Participants puff their own brand liquid on study. SESSIONS 2-5: Participants puff 1 of 4 randomly assigned tobacco flavor formulations at each visit on study. SESSIONS 6-7: Participants puff 1 of 2 randomly assigned nicotine formulations at each visit on study. Participants also undergo collection of saliva samples and optionally undergo collection of oral cell and oral rinse samples throughout study.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Biospecimen Collection
2004
Completed Phase 2
~1700

Find a Location

Who is running the clinical trial?

Roswell Park Cancer InstituteLead Sponsor
402 Previous Clinical Trials
31,035 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,672 Previous Clinical Trials
40,926,369 Total Patients Enrolled
Richard O'ConnorPrincipal InvestigatorRoswell Park
1 Previous Clinical Trials
115 Total Patients Enrolled

Media Library

Vaping (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05876091 — N/A
Tobacco-Related Cancer Research Study Groups: Vaping -
Tobacco-Related Cancer Clinical Trial 2023: Vaping Highlights & Side Effects. Trial Name: NCT05876091 — N/A
Vaping (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05876091 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an opportunity to join this experiment?

"This study, which is recruiting a total of 72 participants, requires applicants to have tobacco-related cancer and be aged between 21 and 55."

Answered by AI

How many individuals are participating in this investigation?

"Correct. Clinicaltrials.gov presents data which suggests that this medical trial is currently recruiting participants; it was first advertised on June 30th 2023, and recently updated on the 23rd of June in the same year. 72 individuals need to be enrolled from a single site."

Answered by AI

Is this research study still enrolling participants?

"According to clinicaltrials.gov, this research is currently enrolling participants. The initial announcement of the project was made on June 30th 2023 and it has since been updated as recently as June 23rd 2023."

Answered by AI

Does this medical research include participants aged 40 or over?

"This research is available to those aged 21 to 55."

Answered by AI
~48 spots leftby Aug 2026